373528008: Neomycin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antibacterial mechanism of action (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antibacterial mechanism of action (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Glycoside\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neomycin	Is a	antibiotique cutané	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin	Has disposition	Antibacterial (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only neomycin and triamcinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only fluocinolone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only hydrocortisone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrocortisone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only lidocaine and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only gramicidin and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorhexidine and neomycin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only neomycin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clobetasol and neomycin and nystatin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only neomycin and triamcinolone in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only fluocinolone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only betamethasone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only hydrocortisone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has precise active ingredient	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has basis of strength substance (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrocortisone 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release ear solution (clinical drug)	Has basis of strength substance (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone- and neomycin-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing betamethasone and neomycin in nasal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone and neomycin only product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrocortisone and neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin- and prednisolone-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Neomycin- and prednisolone-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin and prednisolone in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Neomycin and prednisolone only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution	Has basis of strength substance (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone and neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrocortisone and neomycin only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrocortisone- and neomycin-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydrocortisone and neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Contact dermatitis caused by neomycin	Causative agent (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	Has precise active ingredient	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	Has basis of strength substance (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bacitracin- and neomycin- and sulfacetamide-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bacitracin and neomycin and sulfacetamide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dexamethasone and neomycin and polymyxin B only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	Has basis of strength substance (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3

Start Page 2 of 2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198828019	Neomycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1198828019	Neomycin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1198828019	Neomycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54041000195119	neomicina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69181000195117	Neomycin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310021000077114	néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310021000077114	néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
54041000195119	neomicina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69181000195117	Neomycin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module